Impact of Lipodystrophy on Quality of Life of People Living With HIV- Survey Results
May 28, 2010
FDA Committee Unanimously Votes to Approve Tesamorelin (Egrifta) for Lipodystrophy
June 4, 2010

Survey: Most patients with HIV lipodystrophy are willing to inject Egrifta once a day to reduce their visceral fat

 LIPODYSTROPHY TREATMENT- PATIENT ACCEPTANCE
DownloadCreate Chart1. Has your belly fat increased after starting HIV medications?
answered question 85
skipped question
2
Response
Percent
Response
Count
Yes
92.9% 79
No
7.1% 6
DownloadCreate Chart2. Would you be willing to inject a drug daily under your skin in your belly to decrease your belly fat by 13% in 26 weeks?
answered question 87
skipped question
0
Response
Percent
Response
Count
Yes
83.9% 73
No
16.1% 14
Nelson Vergel
Nelson Vergel
Chemical engineer, 34+ year HIV and cancer survivor, health author and educator . Founder of DiscountedLabs.com , ExcelMale.com , and PowerUSA.org

Comments are closed.